Rainmed Medical Statistics

Total Valuation

Rainmed Medical has a market cap or net worth of HKD 191.52 million. The enterprise value is 3.11 million.

Market Cap	191.52M
Enterprise Value	3.11M

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Rainmed Medical has 1.17 billion shares outstanding.

Current Share Class	1.17B
Shares Outstanding	1.17B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.94%
Owned by Institutions (%)	4.11%
Float	347.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.52
PB Ratio	0.44
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.03
EV / Sales	0.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.02

Financial Position

The company has a current ratio of 4.92, with a Debt / Equity ratio of 0.06.

Current Ratio	4.92
Quick Ratio	4.63
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-106.97

Financial Efficiency

Return on equity (ROE) is -24.85% and return on invested capital (ROIC) is -12.83%.

Return on Equity (ROE)	-24.85%
Return on Assets (ROA)	-12.08%
Return on Invested Capital (ROIC)	-12.83%
Return on Capital Employed (ROCE)	-24.14%
Revenue Per Employee	156,961
Profits Per Employee	-447,331
Employee Count	270
Asset Turnover	0.08
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.75% in the last 52 weeks. The beta is 1.04, so Rainmed Medical's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-41.75%
50-Day Moving Average	0.17
200-Day Moving Average	0.16
Relative Strength Index (RSI)	39.81
Average Volume (20 Days)	647,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rainmed Medical had revenue of HKD 42.38 million and -120.78 million in losses. Loss per share was -0.10.

Revenue	42.38M
Gross Profit	25.40M
Operating Income	-106.55M
Pretax Income	-122.70M
Net Income	-120.78M
EBITDA	-87.28M
EBIT	-106.55M
Loss Per Share	-0.10

Full Income Statement

Balance Sheet

The company has 218.74 million in cash and 27.22 million in debt, giving a net cash position of 191.52 million or 0.16 per share.

Cash & Cash Equivalents	218.74M
Total Debt	27.22M
Net Cash	191.52M
Net Cash Per Share	0.16
Equity (Book Value)	436.22M
Book Value Per Share	0.37
Working Capital	201.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -89.72 million and capital expenditures -47.03 million, giving a free cash flow of -136.75 million.

Operating Cash Flow	-89.72M
Capital Expenditures	-47.03M
Free Cash Flow	-136.75M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross margin is 59.93%, with operating and profit margins of -251.43% and -284.99%.

Gross Margin	59.93%
Operating Margin	-251.43%
Pretax Margin	-289.52%
Profit Margin	-284.99%
EBITDA Margin	-205.94%
EBIT Margin	-251.43%
FCF Margin	n/a

Dividends & Yields

Rainmed Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-63.06%
FCF Yield	-71.40%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rainmed Medical has an Altman Z-Score of -5.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.04
Piotroski F-Score	n/a